Active pharmaceutical ingredients in Malaysian drinking water: consumption, exposure, and human health risk

dc.contributor.authorSze Yee Wee
dc.contributor.authorDidi Erwandi Mohamad Haron
dc.contributor.authorAhmad Zaharin Aris
dc.contributor.authorFatimah Md. Yusoff
dc.contributor.authorSarva Mangala Praveena
dc.coverage.publicationMalaysia
dc.date.accessioned2024-05-20T02:04:45Z
dc.date.available2024-05-20T02:04:45Z
dc.date.issued2020
dc.description.abstractActive pharmaceutical ingredients (APIs) are typical endocrine disruptors found in common pharmaceuticals and personal care products, which are frequently detected in aquatic environments, especially surface water treated for drinking. However, current treatment technologies are inefficient for removing emerging endocrine disruptors, leading to the potential contamination of tap water. This study employed an optimized analytical method comprising solid-phase extraction and liquid chromatography–tandem mass spectrometry (SPE–LC–MS/MS) to detect APIs in tap water in Putrajaya, Malaysia.
dc.identifier.citationWee, S. Y., Haron, D. E. M., Aris, A. Z., Yusoff, F. M., & Praveena, S. M. (2020). Active pharmaceutical ingredients in Malaysian drinking water: consumption, exposure, and human health risk. Environmental geochemistry and health, 42, 3247-3261.
dc.identifier.urihttps://repoemc.ukm.my/handle/123456789/1294
dc.language.isoen
dc.publisherSpringer
dc.publisher.alternativeEnvironmental Geochemistry and Health
dc.subjectPharmaceuticals
dc.subjectEndocrine disruptor
dc.subjectTap water
dc.subjectDrinking water
dc.subjectHuman health risk assessment
dc.subjectRisk quotient
dc.titleActive pharmaceutical ingredients in Malaysian drinking water: consumption, exposure, and human health risk
dc.typeJournal

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
13_Active_pharmaceutical_ingredients_in_Malaysian_drinking_water_consumption_exposure_and_human_health_risk.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format